Authors:
Markwalder, JA
Mutlib, DDCA
Cordova, BC
Klabe, RM
Seitz, SP
Citation: Ja. Markwalder et al., Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz, BIOORG MED, 11(5), 2001, pp. 619-622
Authors:
Carini, DJ
Kaltenbach, RF
Liu, J
Benfield, PA
Boylan, J
Boisclair, M
Brizuela, L
Burton, CR
Cox, S
Grafstrom, R
Harrison, BA
Harrison, K
Akamike, E
Markwalder, JA
Nakano, Y
Seitz, SP
Sharp, DM
Trainor, GL
Sielecki, TM
Citation: Dj. Carini et al., Identification of selective inhibitors of cyclin dependent kinase 4, BIOORG MED, 11(16), 2001, pp. 2209-2211
Citation: B. Schwartz et al., Lipid II: Total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillinbinding protein (PBP) 1b of Eschericia coli, J AM CHEM S, 123(47), 2001, pp. 11638-11643
Authors:
Mutlib, AE
Gerson, RJ
Meunier, PC
Haley, PJ
Chen, H
Gan, LS
Davies, MH
Gemzik, B
Christ, DD
Krahn, DF
Markwalder, JA
Seitz, SP
Robertson, RT
Miwa, GT
Citation: Ae. Mutlib et al., The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats, TOX APPL PH, 169(1), 2000, pp. 102-113
Authors:
Patel, M
Ko, SS
McHugh, RJ
Markwalder, JA
Srivastava, AS
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Trainor, GL
Seitz, SP
Citation: M. Patel et al., Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 9(19), 1999, pp. 2805-2810
Authors:
Mutlib, AE
Chen, H
Nemeth, GA
Markwalder, JA
Seitz, SP
Gan, LS
Christ, DD
Citation: Ae. Mutlib et al., Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: Species differences in the metabolism of efavirenz, DRUG META D, 27(11), 1999, pp. 1319-1333